XT
CELU icon

XTX Topco’s Celularity CELU Stock Holding History

XTX Topco’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17K Sell
12,811
-16,504
-56% -$20.9K ﹤0.01% 3590
2025
Q4 		$32.5K Buy
+29,315
New +$52.6K ﹤0.01% 2945
2025
Q3 		– Sell
-21,452
Closed -$42K – 2639
2025
Q2 		$42K Buy
21,452
+11,057
+106% +$20.1K ﹤0.01% 2048
2025
Q1 		$18K Buy
+10,395
New +$19.7K ﹤0.01% 2166
2024
Q1 		– Sell
-3,417
Closed -$8.46K – 1881
2023
Q4 		$8.46K Buy
3,417
+75
+2% +$163 ﹤0.01% 1442
2023
Q3 		$7.42K Buy
+3,342
New +$12K ﹤0.01% 1439
2022
Q4 		– Sell
-1,235
Closed -$29K – 1157
2022
Q3 		$29K Buy
+1,235
New +$37.5K 0.01% 1053

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return

XTX Topco's CELU Position: Q1 2026 in Review

XTX Topco reduced its Celularity (CELU) stake by 56% in Q1 2026, selling an estimated $20.9K and leaving 12,811 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #3590.

XTX Topco first reported a position in CELU in Q3 2022 and has held it in 7 quarters since. The position peaked at $42K in Q2 2025. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • XTX Topco held 12,811 shares of Celularity worth $17K as of Q1 2026.
  • XTX Topco sold 16,504 Celularity shares in Q1 2026, an estimated $20.9K.
  • Celularity made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3590 holding.
  • XTX Topco first reported a position in Celularity in Q3 2022 and has held it in 7 quarters since.
  • XTX Topco's Celularity position peaked at $42K in Q2 2025.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.